NYSE:IVC - Invacare Stock Price, Forecast & News

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Invacare announced a quarterly dividend on Thursday, November 21st. Shareholders of record on Friday, January 3rd will be paid a dividend of $0.0125 per share on Friday, January 17th. This represents a $0.05 dividend on an annualized basis and a yield of 0.55%. The ex-dividend date is Thursday, January 2nd. View Invacare's Dividend History.

Invacare Co. (NYSE:IVC) issued its earnings results on Wednesday, November, 6th. The health services provider reported ($0.15) EPS for the quarter, beating the Zacks' consensus estimate of ($0.20) by $0.05. The health services provider had revenue of $235.80 million for the quarter, compared to analysts' expectations of $244.81 million. Invacare had a negative net margin of 3.82% and a negative return on equity of 9.30%. The company's quarterly revenue was down 3.6% on a year-over-year basis. During the same quarter last year, the company posted ($0.40) earnings per share. View Invacare's Earnings History.

Invacare is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Invacare.

1 analysts have issued 1-year target prices for Invacare's shares. Their forecasts range from $15.00 to $15.00. On average, they anticipate Invacare's stock price to reach $15.00 in the next year. This suggests a possible upside of 65.0% from the stock's current price. View Analyst Price Targets for Invacare.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Invacare.

Press coverage about IVC stock has trended somewhat positive on Tuesday, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Invacare earned a news impact score of 1.3 on InfoTrie's scale. They also assigned press coverage about the health services provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Invacare.

Some companies that are related to Invacare include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Varian Medical Systems (VAR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include ImmunoGen (IMGN), Opko Health (OPK), ResMed (RMD), Catalyst Pharmaceuticals (CPRX), Immunomedics (IMMU), Lexicon Pharmaceuticals (LXRX), TherapeuticsMD (TXMD), Chesapeake Energy (CHK), NovaBay Pharmaceuticals (NBY) and Abeona Therapeutics (ABEO).

Invacare's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Millennium Management LLC (7.54%), Krensavage Asset Management LLC (3.64%), State Street Corp (3.38%), Granahan Investment Management Inc. MA (1.68%), Keeley Teton Advisors LLC (0.92%) and Stephens Inc. AR (0.87%). Company insiders that own Invacare stock include Anthony Laplaca, Baiju R Shah, C Martin Harris, Clifford D Nastas, Dean J Childers, Kathleen P Leneghan and Matthew E Monaghan. View Institutional Ownership Trends for Invacare.

IVC stock was sold by a variety of institutional investors in the last quarter, including Krensavage Asset Management LLC, Squarepoint Ops LLC, Keeley Teton Advisors LLC, Essex Investment Management Co. LLC, Granahan Investment Management Inc. MA, Adirondack Research & Management Inc. and Nisa Investment Advisors LLC. View Insider Buying and Selling for Invacare.

IVC stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Stephens Inc. AR, Mackay Shields LLC, Dupont Capital Management Corp, Voya Investment Management LLC, BBVA USA Bancshares Inc., State Street Corp and State of Alaska Department of Revenue. Company insiders that have bought Invacare stock in the last two years include Clifford D Nastas, Kathleen P Leneghan and Matthew E Monaghan. View Insider Buying and Selling for Invacare.

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IVC stock can currently be purchased for approximately $9.09.

Invacare has a market capitalization of $305.94 million and generates $972.35 million in revenue each year. The health services provider earns $-43,920,000.00 in net income (profit) each year or ($1.32) on an earnings per share basis. Invacare employs 4,200 workers across the globe.View Additional Information About Invacare.

The official website for Invacare is http://www.invacare.com/.

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44035. The health services provider can be reached via phone at 440-329-6000 or via email at [email protected]